$CHE

Planet Fitness acquired Be-Fit for $114.8M, advancing its international strategy. Roto-Rooter, a Chemed subsidiary, bought a major franchisee for $60.6M. Dine Brands and Wendy's rejected buyout offers, adopting poison pills. Craveworthy Brands to acquire Papa Gino's, adding 160 restaurants. Savory Fund closed $201.5M for franchise growth. Prime QSR acquired Arby's locations. Orchard Jersey secured $17.2M credit for expansion. Mr. Gatti's in Martinsville sold after damage and ownership change.

Chemed Corporation (NYSE:CHE) declared a quarterly cash dividend of $0.70 per share, payable December 4, 2026. This marks the 222nd consecutive quarterly dividend. The company operates VITAS Healthcare and Roto-Rooter. Chemed noted that forward-looking statements involve risks and uncertainties.

Chemed Corp. CEO Kevin J. McNamara sold 2,000 shares at an average price of $537.90, totaling $1,075,800. He now directly owns 82,220 shares, according to an SEC filing.

MCNAMARA KEVIN J (president and CEO) sold 2,000 shares of CHEMED CORP (CHE) at $537.90 ($1.08M total) on 2026-11-03.

LEE SPENCER S (executive vice president) sold 920 shares of CHEMED CORP (CHE) at $537.17 ($0.49M total) on 2026-11-02.

RBC Capital kept Chemed at Sector Perform while raising its price target to $585 from $548, suggesting a 9.7% upside from the recent close. Other recent targets for Chemed range from $620 to $675.

UBS kept its Buy rating on Chemed and increased its price target to $675 from $650, suggesting a 26.6% upside from the Oct 28 close of $533.36, according to the company.

Oppenheimer reaffirmed its Outperform rating for Chemed and increased its price target to $625 from $590, suggesting a 17.2% upside from the Oct 28 close of $533.36.

Analysts upgraded Boeing (BA) to $250, Pentair (PNR) to $65, Chemed (CHE) to $620, Piedmont Realty (PDM) to $11, and Sun Life (SLF) to C$122. Enphase (ENPH) was downgraded to $30, Xylem (XYL) to $90, F5 (FFIV) to $461, Whirlpool (WHR) to $20, and Simply Good Foods (SMPL) to $11. New coverage includes Cavco (CVCO) at $650, MSG Rangers (MSGR) at $228, Alignment (ALHC) with a Hold, Merit Medical (MMSI) at $90, and Atlas Energy (AESI) at $13.

Chemed Corp's (CHE) average price target increased to $592.6 from $571.6, with a range of $548 to $650, implying 16% upside. Analysts' consensus rating shifted to 'Buy' with 3 Buys, 2 Holds, and 1 Sell.